Search

Search bills, members, committees and pages...

HB 1087

Indiana HouseIn House Committee

Summary

HB 1087, “Overdose reversal medication”, was introduced in the House on Jan 5, 2026 by Rep. Mike Andrade (D) with 2 co-sponsors. It was referred to Public Health, and last saw action on Jan 5, 2026: First reading: referred to Committee on Public Health.


Record

Text

HB 1087 has 2 co-sponsors.

hb1087/introduced.txt
Introduced Version
HOUSE BILL No. 1087
_____
DIGEST OF INTRODUCED BILL
Citations Affected: IC 12-21-5-10; IC 20-34-4.5.
Synopsis: Overdose reversal medication. Provides that, subject to
available funding, the division of mental health and addiction may
develop an application to provide funds to a school corporation or
school maintained by a school corporation to obtain a federal Food and
Drug Administration approved opioid overdose reversal medication.
Provides that the state health commissioner shall issue a statewide
standing order, prescription, or protocol for a federal Food and Drug
Administration approved opioid overdose reversal medication for each
public school or school corporation.
Effective: July 1, 2026.
Andrade, Bascom, Pfaff
January 5, 2026, read first time and referred to Committee on Public Health.
2026 IN 1087—LS 6474/DI 152
Introduced
Second Regular Session of the 124th General Assembly (2026)
PRINTING CODE. Amendments: Whenever an existing statute (or a section of the Indiana
Constitution) is being amended, the text of the existing provision will appear in this style type,
additions will appear in this style type, and deletions will appear in this style type.
Additions: Whenever a new statutory provision is being enacted (or a new constitutional
provision adopted), the text of the new provision will appear in this style type. Also, the
word NEW will appear in that style type in the introductory clause of each SECTION that adds
a new provision to the Indiana Code or the Indiana Constitution.
Conflict reconciliation: Text in a statute in this style type or this style type reconciles conflicts
between statutes enacted by the 2025 Regular Session of the General Assembly.
HOUSE BILL No. 1087
A BILL FOR AN ACT to amend the Indiana Code concerning
human services.
Be it enacted by the General Assembly of the State of Indiana:
SECTION 1. IC 12-21-5-10 IS ADDED TO THE INDIANA CODE
AS A NEW SECTION TO READ AS FOLLOWS [EFFECTIVE JULY
1, 2026]: Sec. 10. Subject to available funding, the division may
develop an application to provide funds to a school maintained by
a school corporation or a school corporation on behalf of a school
to obtain a federal Food and Drug Administration approved opioid
overdose reversal medication.
SECTION 2. IC 20-34-4.5-1, AS AMENDED BY P.L.164-2023,
SECTION 55, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
JULY 1, 2026]: Sec. 1. (a) A school or a school corporation may:
(1) fill a prescription or statewide standing order for an
emergency medication; and
(2) store the emergency medication:
(A) if the prescription or statewide standing order is filled by
a school, in the school; or
(B) if the prescription or statewide standing order is filled by
a school corporation, in a school in the school corporation;
2026 IN 1087—LS 6474/DI 152
2
and
(3) work in cooperation with an opioid overdose prevention
organization to carry out the purposes of this chapter;
if a health care provider who is licensed in Indiana and whose scope of
practice includes the prescribing of medication writes the prescription
or the state health commissioner issues a statewide standing order for
the emergency medication for the school or school corporation.
(b) The school shall store the emergency medication in a safe
location in which only school employees have access.
SECTION 3. IC 20-34-4.5-3, AS AMENDED BY P.L.164-2023,
SECTION 56, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
JULY 1, 2026]: Sec. 3. (a) A health care provider who is licensed in
Indiana and whose scope of practice includes the prescribing of
medication may:
(1) write; or
(2) transmit in an electronic format for an electronically
transmitted prescription;
a prescription, drug order, or protocol for an emergency medication for
a school or school corporation.
(b) Except as provided in subsection (d), the state health
commissioner or the state health commissioner's designee who is a
licensed prescriber may issue a statewide standing order, prescription,
or protocol for emergency stock medication for schools or school
corporations.
(c) A pharmacist licensed under IC 25-26 may dispense a valid
prescription, drug order, standing order, or protocol for an emergency
medication issued in the name of a school or school corporation.
(d) The state health commissioner or the state health
commissioner's designee who is a licensed prescriber shall issue a
statewide standing order, prescription, or protocol for a federal
Food and Drug Administration approved opioid overdose reversal
medication, including nasal spray, for each:
(1) school; or
(2) school corporation on behalf of each school.
The standing order, prescription, or protocol shall provide at least
two (2) individual doses of a federal Food and Drug Administration
approved opioid overdose reversal medication per school.
2026 IN 1087—LS 6474/DI 152

Overdose reversal medication. Provides that, subject to available funding, the division of mental health and addiction may develop an application to provide funds to a school corporation or school maintained by a school corporation to obtain a federal Food and Drug Administration approved opioid overdose reversal medication. Provides that the state health commissioner shall issue a statewide standing order, prescription, or protocol for a federal Food and Drug Administration approved opioid overdose reversal medication for each public school or school corporation.

Sponsors

Rep. Mike Andrade (D) sponsors HB 1087, and 2 members have co-sponsored it.

Committees

HB 1087 went before 1 committee: Public Health.

Public Health
Public Health
Referred to · Jan 5, 2026 · 38 Bills

History

HB 1087 has taken 3 actions since Jan 5, 2026.

ChamberAction
Jan 5, 2026
House
Coauthored by Representatives Bascom, Pfaff
Jan 5, 2026
House
Authored by Representative Andrade
Jan 5, 2026
House
First reading: referred to Committee on Public Health

Votes

HB 1087 has not gone to a roll call.


Source: iga.in.gov · legiscan.com